Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Tuberculosis

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

February 2010
1. EVANS J , Segal H
   Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. ANGER HA , Dworkin F, Sharma S, Munsiff SS, et al
   Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. AHMAD Z , Nuermberger EL, Tasneen R, Pinn ML, et al
   Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SYRE H , Ovreas K, Grewal HM
   Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
5. PERDIGAO J , Macedo R, Malaquias A, Ferreira A, et al
   Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.
   J Antimicrob Chemother. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
6. VAN DEN BOOGAARD J , Semvua HH, Boeree MJ, Aarnoutse RE, et al
   Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment.
   J Antimicrob Chemother. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
7. KOH WJ , Shim TS
   Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
   J Antimicrob Chemother. 2009.
   PubMed     Text format     Related articles   
   
   
   August 2009
8. VALVATNE H , Syre H, Kross M, Stavrum R, et al
   Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
   J Antimicrob Chemother. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. SHIKAMA MD , Silva RR, Martins MC, Giampaglia CM, et al
   Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.
   J Antimicrob Chemother. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. YEW WW , Chang KC, Chau CH
    Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
11. SOTGIU G , Lange C, Richardson MD, Matteelli A, et al
    Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
12. KOH WJ , Shim TS
    Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    July 2009
13. SCHON T , Jureen P, Giske CG, Chryssanthou E, et al
    Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. BERGVAL IL , Schuitema AR, Klatser PR, Anthony RM, et al
    Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
15. BOLOTIN S , Alexander DC, Chedore P, Drews SJ, et al
    Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. HAUCK Y , Fabre M, Vergnaud G, Soler C, et al
    Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
17. KOH WJ , Kwon OJ, Gwak H, Chung JW, et al
    Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. TAN CK , Lai CC, Liao CH, Chou CH, et al
    Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    April 2009
19. PIETZKA AT , Indra A, Stoger A, Zeinzinger J, et al
    Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. JENKINS C , Bacon J, Allnutt J, Hatch KA, et al
    Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
21. DEVASIA RA , Blackman A, May C, Eden S, et al
    Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
22. BERESFORD NJ , Mulhearn D, Szczepankiewicz B, Liu G, et al
    Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
23. SLAYDEN RA , Belisle JT
    Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. EVANS JT , Parveen A, Smith GE, Xu L, et al
    Application of denaturing HPLC to rapidly identify rifampicin-resistant Mycobacterium tuberculosis in low- and high-prevalence areas.
    J Antimicrob Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
25. EVANS J , Stead MC, Nicol MP, Segal H, et al
    Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    J Antimicrob Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
26. O'SULLIVAN DM , Hinds J, Butcher PD, Gillespie SH, et al
    Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin.
    J Antimicrob Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. VILLAR R , Vicente E, Solano B, Perez-Silanes S, et al
    In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    J Antimicrob Chemother. 2008;62:547-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
28. HURDLE JG , Lee RB, Budha NR, Carson EI, et al
    A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
    J Antimicrob Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
29. KURABACHEW M , Lu SH, Krastel P, Schmitt EK, et al
    Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. O'SULLIVAN DM , McHugh TD, Gillespie SH
    The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function.
    J Antimicrob Chemother. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
31. MARTIN A , Panaiotov S, Portaels F, Hoffner S, et al
    The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Pfizer.

Amedeo is a Flying Publisher website.    Design: